Global Point-of-Care or Rapid Diagnostics Market Growth 2023-2029

According to our LPI (LP Information) latest study, the global Point-of-Care or Rapid Diagnostics market size was valued at US$ 25110 million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War,  the Point-of-Care or Rapid Diagnostics is forecast to a readjusted size of US$ 29620 million by 2029 with a CAGR of 2.4% during review period. 
The research report highlights the growth potential of the global Point-of-Care or Rapid Diagnostics market. With recovery from influence of COVID-19 and the Russia-Ukraine War, Point-of-Care or Rapid Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Point-of-Care or Rapid Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Point-of-Care or Rapid Diagnostics market.

Point-of-care testing (POCT or bedside testing) is defined as medical diagnostic testing at or near the point of care—that is, at the time and place of patient care.

In our report, blood glucose test strips and blood glucose meter, which mainly used at home, are not included.

In Spain & Portugal Market, Oint-of-Care or Rapid Diagnostics key players include, Roche, Abbott, Danaher, Siemens Healthcare, Bio-Rad Laboratories, etc. Top 5 manufacturers hold a share over 74%.

In terms of product, Intensive Care is the largest segment, with a share over 26%. And in terms of application, the largest application is Hospital, followed by Clinic, Independent Laboratories and Others.

Key Features:
The report on Point-of-Care or Rapid Diagnostics market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Point-of-Care or Rapid Diagnostics market. It may include historical data, market segmentation by Type (e.g., Blood Glucose Testing, Infectious Diseases Testing), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Point-of-Care or Rapid Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Point-of-Care or Rapid Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Point-of-Care or Rapid Diagnostics industry. This include advancements in Point-of-Care or Rapid Diagnostics technology, Point-of-Care or Rapid Diagnostics new entrants, Point-of-Care or Rapid Diagnostics new investment, and other innovations that are shaping the future of Point-of-Care or Rapid Diagnostics.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Point-of-Care or Rapid Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for Point-of-Care or Rapid Diagnostics product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Point-of-Care or Rapid Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Point-of-Care or Rapid Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Point-of-Care or Rapid Diagnostics market. 
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Point-of-Care or Rapid Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Point-of-Care or Rapid Diagnostics market.

Market Segmentation:
Point-of-Care or Rapid Diagnostics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Segmentation by type
    Blood Glucose Testing
    Infectious Diseases Testing
    Cardiac Markers Testing
    Coagulation Testing
    Pregnancy and Fertility Testing
    Blood Gas/Electrolytes Testing
    Urinalysis Testing
    Others

Segmentation by application
    Clinics
    Hospitals
    Laboratory
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Roche
    Abbott
    Johnson & Johnson
    Siemens Healthcare
    Danaher
    Ascensia
    Bio-Rad Laboratories
    BioMerieux
    ARKRAY
    Nova Biomedical
    Trividia Health
    Quidel
    Accriva
    OraSure Technologies
    Helena Laboratories
    A. Menarini Diagnostics
    Abaxis (Zoetis)
    Ortho Clinical Diagnostics
    Phamatech
    Chembio Diagnostics
    Sinocare
    Wondfo
    Yuwell
    Runbio
    KHB
    Wuhan EasyDiagnosis Biomedicine
    DAAN GENE

Key Questions Addressed in this Report
What is the 10-year outlook for the global Point-of-Care or Rapid Diagnostics market?
What factors are driving Point-of-Care or Rapid Diagnostics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Point-of-Care or Rapid Diagnostics market opportunities vary by end market size?
How does Point-of-Care or Rapid Diagnostics break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

List of Tables
    Table 1. Point-of-Care or Rapid Diagnostics Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
    Table 2. Point-of-Care or Rapid Diagnostics Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
    Table 3. Major Players of Blood Glucose Testing
    Table 4. Major Players of Infectious Diseases Testing
    Table 5. Major Players of Cardiac Markers Testing
    Table 6. Major Players of Coagulation Testing
    Table 7. Major Players of Pregnancy and Fertility Testing
    Table 8. Major Players of Blood Gas/Electrolytes Testing
    Table 9. Major Players of Urinalysis Testing
    Table 10. Major Players of Others
    Table 11. Global Point-of-Care or Rapid Diagnostics Sales by Type (2018-2023) & (K Units)
    Table 12. Global Point-of-Care or Rapid Diagnostics Sales Market Share by Type (2018-2023)
    Table 13. Global Point-of-Care or Rapid Diagnostics Revenue by Type (2018-2023) & ($ million)
    Table 14. Global Point-of-Care or Rapid Diagnostics Revenue Market Share by Type (2018-2023)
    Table 15. Global Point-of-Care or Rapid Diagnostics Sale Price by Type (2018-2023) & (USD/Unit)
    Table 16. Global Point-of-Care or Rapid Diagnostics Sales by Application (2018-2023) & (K Units)
    Table 17. Global Point-of-Care or Rapid Diagnostics Sales Market Share by Application (2018-2023)
    Table 18. Global Point-of-Care or Rapid Diagnostics Revenue by Application (2018-2023)
    Table 19. Global Point-of-Care or Rapid Diagnostics Revenue Market Share by Application (2018-2023)
    Table 20. Global Point-of-Care or Rapid Diagnostics Sale Price by Application (2018-2023) & (USD/Unit)
    Table 21. Global Point-of-Care or Rapid Diagnostics Sales by Company (2018-2023) & (K Units)
    Table 22. Global Point-of-Care or Rapid Diagnostics Sales Market Share by Company (2018-2023)
    Table 23. Global Point-of-Care or Rapid Diagnostics Revenue by Company (2018-2023) ($ Millions)
    Table 24. Global Point-of-Care or Rapid Diagnostics Revenue Market Share by Company (2018-2023)
    Table 25. Global Point-of-Care or Rapid Diagnostics Sale Price by Company (2018-2023) & (USD/Unit)
    Table 26. Key Manufacturers Point-of-Care or Rapid Diagnostics Producing Area Distribution and Sales Area
    Table 27. Players Point-of-Care or Rapid Diagnostics Products Offered
    Table 28. Point-of-Care or Rapid Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
    Table 29. New Products and Potential Entrants
    Table 30. Mergers & Acquisitions, Expansion
    Table 31. Global Point-of-Care or Rapid Diagnostics Sales by Geographic Region (2018-2023) & (K Units)
    Table 32. Global Point-of-Care or Rapid Diagnostics Sales Market Share Geographic Region (2018-2023)
    Table 33. Global Point-of-Care or Rapid Diagnostics Revenue by Geographic Region (2018-2023) & ($ millions)
    Table 34. Global Point-of-Care or Rapid Diagnostics Revenue Market Share by Geographic Region (2018-2023)
    Table 35. Global Point-of-Care or Rapid Diagnostics Sales by Country/Region (2018-2023) & (K Units)
    Table 36. Global Point-of-Care or Rapid Diagnostics Sales Market Share by Country/Region (2018-2023)
    Table 37. Global Point-of-Care or Rapid Diagnostics Revenue by Country/Region (2018-2023) & ($ millions)
    Table 38. Global Point-of-Care or Rapid Diagnostics Revenue Market Share by Country/Region (2018-2023)
    Table 39. Americas Point-of-Care or Rapid Diagnostics Sales by Country (2018-2023) & (K Units)
    Table 40. Americas Point-of-Care or Rapid Diagnostics Sales Market Share by Country (2018-2023)
    Table 41. Americas Point-of-Care or Rapid Diagnostics Revenue by Country (2018-2023) & ($ Millions)
    Table 42. Americas Point-of-Care or Rapid Diagnostics Revenue Market Share by Country (2018-2023)
    Table 43. Americas Point-of-Care or Rapid Diagnostics Sales by Type (2018-2023) & (K Units)
    Table 44. Americas Point-of-Care or Rapid Diagnostics Sales by Application (2018-2023) & (K Units)
    Table 45. APAC Point-of-Care or Rapid Diagnostics Sales by Region (2018-2023) & (K Units)
    Table 46. APAC Point-of-Care or Rapid Diagnostics Sales Market Share by Region (2018-2023)
    Table 47. APAC Point-of-Care or Rapid Diagnostics Revenue by Region (2018-2023) & ($ Millions)
    Table 48. APAC Point-of-Care or Rapid Diagnostics Revenue Market Share by Region (2018-2023)
    Table 49. APAC Point-of-Care or Rapid Diagnostics Sales by Type (2018-2023) & (K Units)
    Table 50. APAC Point-of-Care or Rapid Diagnostics Sales by Application (2018-2023) & (K Units)
    Table 51. Europe Point-of-Care or Rapid Diagnostics Sales by Country (2018-2023) & (K Units)
    Table 52. Europe Point-of-Care or Rapid Diagnostics Sales Market Share by Country (2018-2023)
    Table 53. Europe Point-of-Care or Rapid Diagnostics Revenue by Country (2018-2023) & ($ Millions)
    Table 54. Europe Point-of-Care or Rapid Diagnostics Revenue Market Share by Country (2018-2023)
    Table 55. Europe Point-of-Care or Rapid Diagnostics Sales by Type (2018-2023) & (K Units)
    Table 56. Europe Point-of-Care or Rapid Diagnostics Sales by Application (2018-2023) & (K Units)
    Table 57. Middle East & Africa Point-of-Care or Rapid Diagnostics Sales by Country (2018-2023) & (K Units)
    Table 58. Middle East & Africa Point-of-Care or Rapid Diagnostics Sales Market Share by Country (2018-2023)
    Table 59. Middle East & Africa Point-of-Care or Rapid Diagnostics Revenue by Country (2018-2023) & ($ Millions)
    Table 60. Middle East & Africa Point-of-Care or Rapid Diagnostics Revenue Market Share by Country (2018-2023)
    Table 61. Middle East & Africa Point-of-Care or Rapid Diagnostics Sales by Type (2018-2023) & (K Units)
    Table 62. Middle East & Africa Point-of-Care or Rapid Diagnostics Sales by Application (2018-2023) & (K Units)
    Table 63. Key Market Drivers & Growth Opportunities of Point-of-Care or Rapid Diagnostics
    Table 64. Key Market Challenges & Risks of Point-of-Care or Rapid Diagnostics
    Table 65. Key Industry Trends of Point-of-Care or Rapid Diagnostics
    Table 66. Point-of-Care or Rapid Diagnostics Raw Material
    Table 67. Key Suppliers of Raw Materials
    Table 68. Point-of-Care or Rapid Diagnostics Distributors List
    Table 69. Point-of-Care or Rapid Diagnostics Customer List
    Table 70. Global Point-of-Care or Rapid Diagnostics Sales Forecast by Region (2024-2029) & (K Units)
    Table 71. Global Point-of-Care or Rapid Diagnostics Revenue Forecast by Region (2024-2029) & ($ millions)
    Table 72. Americas Point-of-Care or Rapid Diagnostics Sales Forecast by Country (2024-2029) & (K Units)
    Table 73. Americas Point-of-Care or Rapid Diagnostics Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 74. APAC Point-of-Care or Rapid Diagnostics Sales Forecast by Region (2024-2029) & (K Units)
    Table 75. APAC Point-of-Care or Rapid Diagnostics Revenue Forecast by Region (2024-2029) & ($ millions)
    Table 76. Europe Point-of-Care or Rapid Diagnostics Sales Forecast by Country (2024-2029) & (K Units)
    Table 77. Europe Point-of-Care or Rapid Diagnostics Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 78. Middle East & Africa Point-of-Care or Rapid Diagnostics Sales Forecast by Country (2024-2029) & (K Units)
    Table 79. Middle East & Africa Point-of-Care or Rapid Diagnostics Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 80. Global Point-of-Care or Rapid Diagnostics Sales Forecast by Type (2024-2029) & (K Units)
    Table 81. Global Point-of-Care or Rapid Diagnostics Revenue Forecast by Type (2024-2029) & ($ Millions)
    Table 82. Global Point-of-Care or Rapid Diagnostics Sales Forecast by Application (2024-2029) & (K Units)
    Table 83. Global Point-of-Care or Rapid Diagnostics Revenue Forecast by Application (2024-2029) & ($ Millions)
    Table 84. Roche Basic Information, Point-of-Care or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
    Table 85. Roche Point-of-Care or Rapid Diagnostics Product Portfolios and Specifications
    Table 86. Roche Point-of-Care or Rapid Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 87. Roche Main Business
    Table 88. Roche Latest Developments
    Table 89. Abbott Basic Information, Point-of-Care or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
    Table 90. Abbott Point-of-Care or Rapid Diagnostics Product Portfolios and Specifications
    Table 91. Abbott Point-of-Care or Rapid Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 92. Abbott Main Business
    Table 93. Abbott Latest Developments
    Table 94. Johnson & Johnson Basic Information, Point-of-Care or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
    Table 95. Johnson & Johnson Point-of-Care or Rapid Diagnostics Product Portfolios and Specifications
    Table 96. Johnson & Johnson Point-of-Care or Rapid Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 97. Johnson & Johnson Main Business
    Table 98. Johnson & Johnson Latest Developments
    Table 99. Siemens Healthcare Basic Information, Point-of-Care or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
    Table 100. Siemens Healthcare Point-of-Care or Rapid Diagnostics Product Portfolios and Specifications
    Table 101. Siemens Healthcare Point-of-Care or Rapid Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 102. Siemens Healthcare Main Business
    Table 103. Siemens Healthcare Latest Developments
    Table 104. Danaher Basic Information, Point-of-Care or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
    Table 105. Danaher Point-of-Care or Rapid Diagnostics Product Portfolios and Specifications
    Table 106. Danaher Point-of-Care or Rapid Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 107. Danaher Main Business
    Table 108. Danaher Latest Developments
    Table 109. Ascensia Basic Information, Point-of-Care or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
    Table 110. Ascensia Point-of-Care or Rapid Diagnostics Product Portfolios and Specifications
    Table 111. Ascensia Point-of-Care or Rapid Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 112. Ascensia Main Business
    Table 113. Ascensia Latest Developments
    Table 114. Bio-Rad Laboratories Basic Information, Point-of-Care or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
    Table 115. Bio-Rad Laboratories Point-of-Care or Rapid Diagnostics Product Portfolios and Specifications
    Table 116. Bio-Rad Laboratories Point-of-Care or Rapid Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 117. Bio-Rad Laboratories Main Business
    Table 118. Bio-Rad Laboratories Latest Developments
    Table 119. BioMerieux Basic Information, Point-of-Care or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
    Table 120. BioMerieux Point-of-Care or Rapid Diagnostics Product Portfolios and Specifications
    Table 121. BioMerieux Point-of-Care or Rapid Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 122. BioMerieux Main Business
    Table 123. BioMerieux Latest Developments
    Table 124. ARKRAY Basic Information, Point-of-Care or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
    Table 125. ARKRAY Point-of-Care or Rapid Diagnostics Product Portfolios and Specifications
    Table 126. ARKRAY Point-of-Care or Rapid Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 127. ARKRAY Main Business
    Table 128. ARKRAY Latest Developments
    Table 129. Nova Biomedical Basic Information, Point-of-Care or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
    Table 130. Nova Biomedical Point-of-Care or Rapid Diagnostics Product Portfolios and Specifications
    Table 131. Nova Biomedical Point-of-Care or Rapid Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 132. Nova Biomedical Main Business
    Table 133. Nova Biomedical Latest Developments
    Table 134. Trividia Health Basic Information, Point-of-Care or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
    Table 135. Trividia Health Point-of-Care or Rapid Diagnostics Product Portfolios and Specifications
    Table 136. Trividia Health Point-of-Care or Rapid Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 137. Trividia Health Main Business
    Table 138. Trividia Health Latest Developments
    Table 139. Quidel Basic Information, Point-of-Care or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
    Table 140. Quidel Point-of-Care or Rapid Diagnostics Product Portfolios and Specifications
    Table 141. Quidel Point-of-Care or Rapid Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 142. Quidel Main Business
    Table 143. Quidel Latest Developments
    Table 144. Accriva Basic Information, Point-of-Care or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
    Table 145. Accriva Point-of-Care or Rapid Diagnostics Product Portfolios and Specifications
    Table 146. Accriva Point-of-Care or Rapid Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 147. Accriva Main Business
    Table 148. Accriva Latest Developments
    Table 149. OraSure Technologies Basic Information, Point-of-Care or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
    Table 150. OraSure Technologies Point-of-Care or Rapid Diagnostics Product Portfolios and Specifications
    Table 151. OraSure Technologies Point-of-Care or Rapid Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 152. OraSure Technologies Main Business
    Table 153. OraSure Technologies Latest Developments
    Table 154. Helena Laboratories Basic Information, Point-of-Care or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
    Table 155. Helena Laboratories Point-of-Care or Rapid Diagnostics Product Portfolios and Specifications
    Table 156. Helena Laboratories Point-of-Care or Rapid Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 157. Helena Laboratories Main Business
    Table 158. Helena Laboratories Latest Developments
    Table 159. A. Menarini Diagnostics Basic Information, Point-of-Care or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
    Table 160. A. Menarini Diagnostics Point-of-Care or Rapid Diagnostics Product Portfolios and Specifications
    Table 161. A. Menarini Diagnostics Point-of-Care or Rapid Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 162. A. Menarini Diagnostics Main Business
    Table 163. A. Menarini Diagnostics Latest Developments
    Table 164. Abaxis (Zoetis) Basic Information, Point-of-Care or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
    Table 165. Abaxis (Zoetis) Point-of-Care or Rapid Diagnostics Product Portfolios and Specifications
    Table 166. Abaxis (Zoetis) Point-of-Care or Rapid Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 167. Abaxis (Zoetis) Main Business
    Table 168. Abaxis (Zoetis) Latest Developments
    Table 169. Ortho Clinical Diagnostics Basic Information, Point-of-Care or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
    Table 170. Ortho Clinical Diagnostics Point-of-Care or Rapid Diagnostics Product Portfolios and Specifications
    Table 171. Ortho Clinical Diagnostics Point-of-Care or Rapid Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 172. Ortho Clinical Diagnostics Main Business
    Table 173. Ortho Clinical Diagnostics Latest Developments
    Table 174. Phamatech Basic Information, Point-of-Care or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
    Table 175. Phamatech Point-of-Care or Rapid Diagnostics Product Portfolios and Specifications
    Table 176. Phamatech Point-of-Care or Rapid Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 177. Phamatech Main Business
    Table 178. Phamatech Latest Developments
    Table 179. Chembio Diagnostics Basic Information, Point-of-Care or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
    Table 180. Chembio Diagnostics Point-of-Care or Rapid Diagnostics Product Portfolios and Specifications
    Table 181. Chembio Diagnostics Point-of-Care or Rapid Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 182. Chembio Diagnostics Main Business
    Table 183. Chembio Diagnostics Latest Developments
    Table 184. Sinocare Basic Information, Point-of-Care or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
    Table 185. Sinocare Point-of-Care or Rapid Diagnostics Product Portfolios and Specifications
    Table 186. Sinocare Point-of-Care or Rapid Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 187. Sinocare Main Business
    Table 188. Sinocare Latest Developments
    Table 189. Wondfo Basic Information, Point-of-Care or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
    Table 190. Wondfo Point-of-Care or Rapid Diagnostics Product Portfolios and Specifications
    Table 191. Wondfo Point-of-Care or Rapid Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 192. Wondfo Main Business
    Table 193. Wondfo Latest Developments
    Table 194. Yuwell Basic Information, Point-of-Care or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
    Table 195. Yuwell Point-of-Care or Rapid Diagnostics Product Portfolios and Specifications
    Table 196. Yuwell Point-of-Care or Rapid Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 197. Yuwell Main Business
    Table 198. Yuwell Latest Developments
    Table 199. Runbio Basic Information, Point-of-Care or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
    Table 200. Runbio Point-of-Care or Rapid Diagnostics Product Portfolios and Specifications
    Table 201. Runbio Point-of-Care or Rapid Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 202. Runbio Main Business
    Table 203. Runbio Latest Developments
    Table 204. KHB Basic Information, Point-of-Care or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
    Table 205. KHB Point-of-Care or Rapid Diagnostics Product Portfolios and Specifications
    Table 206. KHB Point-of-Care or Rapid Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 207. KHB Main Business
    Table 208. KHB Latest Developments
    Table 209. Wuhan EasyDiagnosis Biomedicine Basic Information, Point-of-Care or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
    Table 210. Wuhan EasyDiagnosis Biomedicine Point-of-Care or Rapid Diagnostics Product Portfolios and Specifications
    Table 211. Wuhan EasyDiagnosis Biomedicine Point-of-Care or Rapid Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 212. Wuhan EasyDiagnosis Biomedicine Main Business
    Table 213. Wuhan EasyDiagnosis Biomedicine Latest Developments
    Table 214. DAAN GENE Basic Information, Point-of-Care or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
    Table 215. DAAN GENE Point-of-Care or Rapid Diagnostics Product Portfolios and Specifications
    Table 216. DAAN GENE Point-of-Care or Rapid Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 217. DAAN GENE Main Business
    Table 218. DAAN GENE Latest Developments
List of Figures
    Figure 1. Picture of Point-of-Care or Rapid Diagnostics
    Figure 2. Point-of-Care or Rapid Diagnostics Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Point-of-Care or Rapid Diagnostics Sales Growth Rate 2018-2029 (K Units)
    Figure 7. Global Point-of-Care or Rapid Diagnostics Revenue Growth Rate 2018-2029 ($ Millions)
    Figure 8. Point-of-Care or Rapid Diagnostics Sales by Region (2018, 2022 & 2029) & ($ Millions)
    Figure 9. Product Picture of Blood Glucose Testing
    Figure 10. Product Picture of Infectious Diseases Testing
    Figure 11. Product Picture of Cardiac Markers Testing
    Figure 12. Product Picture of Coagulation Testing
    Figure 13. Product Picture of Pregnancy and Fertility Testing
    Figure 14. Product Picture of Blood Gas/Electrolytes Testing
    Figure 15. Product Picture of Urinalysis Testing
    Figure 16. Product Picture of Others
    Figure 17. Global Point-of-Care or Rapid Diagnostics Sales Market Share by Type in 2022
    Figure 18. Global Point-of-Care or Rapid Diagnostics Revenue Market Share by Type (2018-2023)
    Figure 19. Point-of-Care or Rapid Diagnostics Consumed in Clinics
    Figure 20. Global Point-of-Care or Rapid Diagnostics Market: Clinics (2018-2023) & (K Units)
    Figure 21. Point-of-Care or Rapid Diagnostics Consumed in Hospitals
    Figure 22. Global Point-of-Care or Rapid Diagnostics Market: Hospitals (2018-2023) & (K Units)
    Figure 23. Point-of-Care or Rapid Diagnostics Consumed in Laboratory
    Figure 24. Global Point-of-Care or Rapid Diagnostics Market: Laboratory (2018-2023) & (K Units)
    Figure 25. Point-of-Care or Rapid Diagnostics Consumed in Others
    Figure 26. Global Point-of-Care or Rapid Diagnostics Market: Others (2018-2023) & (K Units)
    Figure 27. Global Point-of-Care or Rapid Diagnostics Sales Market Share by Application (2022)
    Figure 28. Global Point-of-Care or Rapid Diagnostics Revenue Market Share by Application in 2022
    Figure 29. Point-of-Care or Rapid Diagnostics Sales Market by Company in 2022 (K Units)
    Figure 30. Global Point-of-Care or Rapid Diagnostics Sales Market Share by Company in 2022
    Figure 31. Point-of-Care or Rapid Diagnostics Revenue Market by Company in 2022 ($ Million)
    Figure 32. Global Point-of-Care or Rapid Diagnostics Revenue Market Share by Company in 2022
    Figure 33. Global Point-of-Care or Rapid Diagnostics Sales Market Share by Geographic Region (2018-2023)
    Figure 34. Global Point-of-Care or Rapid Diagnostics Revenue Market Share by Geographic Region in 2022
    Figure 35. Americas Point-of-Care or Rapid Diagnostics Sales 2018-2023 (K Units)
    Figure 36. Americas Point-of-Care or Rapid Diagnostics Revenue 2018-2023 ($ Millions)
    Figure 37. APAC Point-of-Care or Rapid Diagnostics Sales 2018-2023 (K Units)
    Figure 38. APAC Point-of-Care or Rapid Diagnostics Revenue 2018-2023 ($ Millions)
    Figure 39. Europe Point-of-Care or Rapid Diagnostics Sales 2018-2023 (K Units)
    Figure 40. Europe Point-of-Care or Rapid Diagnostics Revenue 2018-2023 ($ Millions)
    Figure 41. Middle East & Africa Point-of-Care or Rapid Diagnostics Sales 2018-2023 (K Units)
    Figure 42. Middle East & Africa Point-of-Care or Rapid Diagnostics Revenue 2018-2023 ($ Millions)
    Figure 43. Americas Point-of-Care or Rapid Diagnostics Sales Market Share by Country in 2022
    Figure 44. Americas Point-of-Care or Rapid Diagnostics Revenue Market Share by Country in 2022
    Figure 45. Americas Point-of-Care or Rapid Diagnostics Sales Market Share by Type (2018-2023)
    Figure 46. Americas Point-of-Care or Rapid Diagnostics Sales Market Share by Application (2018-2023)
    Figure 47. United States Point-of-Care or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions)
    Figure 48. Canada Point-of-Care or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions)
    Figure 49. Mexico Point-of-Care or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions)
    Figure 50. Brazil Point-of-Care or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions)
    Figure 51. APAC Point-of-Care or Rapid Diagnostics Sales Market Share by Region in 2022
    Figure 52. APAC Point-of-Care or Rapid Diagnostics Revenue Market Share by Regions in 2022
    Figure 53. APAC Point-of-Care or Rapid Diagnostics Sales Market Share by Type (2018-2023)
    Figure 54. APAC Point-of-Care or Rapid Diagnostics Sales Market Share by Application (2018-2023)
    Figure 55. China Point-of-Care or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions)
    Figure 56. Japan Point-of-Care or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions)
    Figure 57. South Korea Point-of-Care or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions)
    Figure 58. Southeast Asia Point-of-Care or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions)
    Figure 59. India Point-of-Care or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions)
    Figure 60. Australia Point-of-Care or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions)
    Figure 61. China Taiwan Point-of-Care or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions)
    Figure 62. Europe Point-of-Care or Rapid Diagnostics Sales Market Share by Country in 2022
    Figure 63. Europe Point-of-Care or Rapid Diagnostics Revenue Market Share by Country in 2022
    Figure 64. Europe Point-of-Care or Rapid Diagnostics Sales Market Share by Type (2018-2023)
    Figure 65. Europe Point-of-Care or Rapid Diagnostics Sales Market Share by Application (2018-2023)
    Figure 66. Germany Point-of-Care or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions)
    Figure 67. France Point-of-Care or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions)
    Figure 68. UK Point-of-Care or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions)
    Figure 69. Italy Point-of-Care or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions)
    Figure 70. Russia Point-of-Care or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions)
    Figure 71. Middle East & Africa Point-of-Care or Rapid Diagnostics Sales Market Share by Country in 2022
    Figure 72. Middle East & Africa Point-of-Care or Rapid Diagnostics Revenue Market Share by Country in 2022
    Figure 73. Middle East & Africa Point-of-Care or Rapid Diagnostics Sales Market Share by Type (2018-2023)
    Figure 74. Middle East & Africa Point-of-Care or Rapid Diagnostics Sales Market Share by Application (2018-2023)
    Figure 75. Egypt Point-of-Care or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions)
    Figure 76. South Africa Point-of-Care or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions)
    Figure 77. Israel Point-of-Care or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions)
    Figure 78. Turkey Point-of-Care or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions)
    Figure 79. GCC Country Point-of-Care or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions)
    Figure 80. Manufacturing Cost Structure Analysis of Point-of-Care or Rapid Diagnostics in 2022
    Figure 81. Manufacturing Process Analysis of Point-of-Care or Rapid Diagnostics
    Figure 82. Industry Chain Structure of Point-of-Care or Rapid Diagnostics
    Figure 83. Channels of Distribution
    Figure 84. Global Point-of-Care or Rapid Diagnostics Sales Market Forecast by Region (2024-2029)
    Figure 85. Global Point-of-Care or Rapid Diagnostics Revenue Market Share Forecast by Region (2024-2029)
    Figure 86. Global Point-of-Care or Rapid Diagnostics Sales Market Share Forecast by Type (2024-2029)
    Figure 87. Global Point-of-Care or Rapid Diagnostics Revenue Market Share Forecast by Type (2024-2029)
    Figure 88. Global Point-of-Care or Rapid Diagnostics Sales Market Share Forecast by Application (2024-2029)
    Figure 89. Global Point-of-Care or Rapid Diagnostics Revenue Market Share Forecast by Application (2024-2029)

Roche
Abbott
Johnson & Johnson
Siemens Healthcare
Danaher
Ascensia
Bio-Rad Laboratories
BioMerieux
ARKRAY
Nova Biomedical
Trividia Health
Quidel
Accriva
OraSure Technologies
Helena Laboratories
A. Menarini Diagnostics
Abaxis (Zoetis)
Ortho Clinical Diagnostics
Phamatech
Chembio Diagnostics
Sinocare
Wondfo
Yuwell
Runbio
KHB
Wuhan EasyDiagnosis Biomedicine
DAAN GENE

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

• Primary Source
  Players/Suppliers
  Industry Experts
  Distributors/Traders
  Opinion Leaders
  Front-line Staff
  Marketing Executives

  Secondary Source
  Journals and Periodicals
  Government Bodies
  Annual Reports
  Presentations
  Paid Databases
  LPI Internal Repository

• Data Synthesis
  Information Gathering
  Collation of Data
  Estimation of Key Figures
  Analysis of Derived Insights

  Data Validation
  Triangulation with Data Models
  Reference Against Proprietary
  Databases
  Corroboration with Industry Experts

• Qualitative Analysis
  Market drivers
  Market challenges
  Market trends
  Five forces analysis

  Qualitative Analysis
  Market size and forecast
  Market segmentation
  Geographical insights
  Competitive landscape